Person profile
Roles
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ACELYRIN, Inc.
11 Jun 24
4
Sagimet Biosciences Inc.
7 Jun 24
4
Progyny, Inc.
28 May 24
4
Vera Therapeutics, Inc.
17 May 24
4
Kyverna Therapeutics, Inc.
14 Feb 24
3
Kyverna Therapeutics, Inc.
7 Feb 24
4
Sagimet Biosciences Inc.
20 Jul 23
3
Sagimet Biosciences Inc.
13 Jul 23
4
Progyny, Inc.
27 Jun 23
4
Progyny, Inc.
13 Jun 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Jun 24 | SLRN Acelyrin | Director Stock Option Common Stock | Grant | Acquire A | No | No | 4.46 | 92,158 | 411.02 k | 92,158 |
5 Jun 24 | SGMT Sagimet Biosciences | Stock Option Series A Common Stock | Grant | Acquire A | No | No | 4.64 | 51,459 | 238.77 k | 51,459 |
23 May 24 | PGNY Progyny | Common Stock | Grant | Acquire A | No | No | 0 | 7,206 | 0.00 | 43,416 |
23 May 24 | PGNY Progyny | Stock Option Common Stock | Grant | Acquire A | No | No | 27.15 | 26,926 | 731.04 k | 26,926 |
15 May 24 | VERA Vera Therapeutics Inc - Ordinary Shares | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 42.69 | 14,000 | 597.66 k | 14,000 |
12 Feb 24 | KYTX Kyverna Therapeutics | Common Stock | Conversion | Acquire C | Yes | No | 0 | 735,984 | 0.00 | 735,984 |
12 Feb 24 | KYTX Kyverna Therapeutics | Common Stock | Conversion | Acquire C | Yes | No | 0 | 3,787,940 | 0.00 | 3,787,940 |
12 Feb 24 | KYTX Kyverna Therapeutics | Series B Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 3,349,538 | 0.00 | 0 |
12 Feb 24 | KYTX Kyverna Therapeutics | Series B Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 4,006,624 | 0.00 | 0 |
12 Feb 24 | KYTX Kyverna Therapeutics | Series A-2 Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 8,830,901 | 0.00 | 0 |